Funder
National Institutes of Health
American Thoracic Society
aTyr Pharma
Subject
Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine
Reference35 articles.
1. New advances in the management of pulmonary sarcoidosis;Culver;BMJ,2019
2. ERS clinical practice guidelines on treatment of sarcoidosis;Baughman;Eur Respir J,2021
3. Misconceptions regarding symptoms of sarcoidosis;Drent;Lancet Respir Med,2021
4. Management of chronic respiratory failure in interstitial lung diseases: overview and clinical insights;Faverio;Int J Med,2019
5. Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study;Schutt;Respir Med,2010
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Treatment of Granulomatous Inflammation in Pulmonary Sarcoidosis;Journal of Clinical Medicine;2024-01-27
2. Anti-Granulomatous Therapy for Pulmonary Sarcoidosis;Sarcoidosis - Diagnosis, Research, and Therapy of a Granulomatous Disease of Unknown Etiology - To remind what we already knew and learn something new about this disease [Working Title];2024-01-06
3. Emerging Therapeutic Options for Refractory Pulmonary Sarcoidosis: The Evidence and Proposed Mechanisms of Action;Journal of Clinical Medicine;2023-12-19
4. Exposure-response analyses of efzofitimod in patients with pulmonary sarcoidosis;Frontiers in Pharmacology;2023-10-03
5. 多様な臓器病変とサルコイドーシスの病態に関する臨床的検討;The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders;2023-10-01